Terms: = Cervical cancer AND Ki-67
626 results:
1. Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2-3 in Thai women infected with high-risk types of human papillomavirus.
Srisuttayasathien M; Kantathavorn N; Luasiripanthu T; Petchjorm S; Samrarn J; Ittiamornlert P; Krisorakun W; Vanichtantikul A; Wetcho T; Saeloo S
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):192-198. PubMed ID: 38485314
[TBL] [Abstract] [Full Text] [Related]
2. Correlation between high-risk HPV infection and p16/ki-67 abnormalities in Pap samples in a South Eastern Europe cohort.
Shalaby NA; Tudorescu-Morjan C; Manole CG; Iacata AA; Popovici ML; Grecu LI; Curici A
J Med Virol; 2024 Mar; 96(3):e29524. PubMed ID: 38483062
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer.
Wu J; Wang R; Chen W; Wu Y; Xiao L
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():210-216. PubMed ID: 38301499
[TBL] [Abstract] [Full Text] [Related]
4. Neuroendocrine carcinoma of the uterine cervix with extensive pagetoid spread pattern.
Sakurai A; Yamanoi K; Yamaguchi K; Hamanishi J; Minamiguchi S; Mandai M
J Obstet Gynaecol Res; 2024 Apr; 50(4):758-763. PubMed ID: 38297984
[TBL] [Abstract] [Full Text] [Related]
5. Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication.
Fujii S; Hasegawa K; Maehara T; Kurppa KJ; Heikinheimo K; Warner KA; Maruyama S; Tajiri Y; Nör JE; Tanuma JI; Kawano S; Kiyoshima T
Pathol Res Pract; 2024 Feb; 254():155148. PubMed ID: 38277753
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistopathological Study of Papillary Squamotransitional Carcinoma of Uterine Cervix.
Dhande B; Khandeparkar SGS; Gogate BP; Joshi AR; Gosavi SS; Mishra PV
Gulf J Oncolog; 2024 Jan; 1(44):16-24. PubMed ID: 38205568
[TBL] [Abstract] [Full Text] [Related]
7. Expression and clinical diagnostic value of CCHE1 in breast cancer.
Zhao F; Zhou W; Xin R; Miao X
Mutagenesis; 2024 Mar; 39(2):141-145. PubMed ID: 38150355
[TBL] [Abstract] [Full Text] [Related]
8. Inhibitory actions of oxyresveratrol on the PI3K/AKT signaling cascade in cervical cancer cells.
Tan B; Wikan N; Lin S; Thaklaewphan P; Potikanond S; Nimlamool W
Biomed Pharmacother; 2024 Jan; 170():115982. PubMed ID: 38056236
[TBL] [Abstract] [Full Text] [Related]
9. Risk Factors for Persistence or Recurrence of High-Grade cervical Squamous Intraepithelial Lesions.
Bittencourt DD; Zanine RM; Sebastião APM; Ribas CM
Rev Col Bras Cir; 2023; 50():e20233537. PubMed ID: 38055549
[TBL] [Abstract] [Full Text] [Related]
10. The cadherin protein CDH19 mediates cervical carcinoma progression by regulating AKT/NF-κB signaling.
Yu J; Sun X; Yu Y; Cui X
Acta Biochim Pol; 2023 Dec; 70(4):955-961. PubMed ID: 38052007
[TBL] [Abstract] [Full Text] [Related]
11. The effects of the LaSota strain of oncolytic Newcastle disease virus vaccine on cervical intraepithelial neoplasia Patients-Clinical cohort study.
Sharifi N; Bouzari M; Keyvani H; Mehdi Ranjbar M
Int Immunopharmacol; 2024 Jan; 126():111296. PubMed ID: 38041958
[TBL] [Abstract] [Full Text] [Related]
12. Delayed vaccine-induced CD8
van der Sluis TC; van Haften FJ; van Duikeren S; Pardieck IN; de Graaf JF; Vleeshouwers W; van der Maaden K; Melief CJM; van der Burg SH; Arens R
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030302
[TBL] [Abstract] [Full Text] [Related]
13. HDAC1 suppresses radiotherapy sensitivity in cervical cancer via regulating HIF-1α/VEGF signaling pathway.
Liu L; Gu K; Hua D
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):132-140. PubMed ID: 38015530
[TBL] [Abstract] [Full Text] [Related]
14. The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation.
Ran XM; Xiao H; Tang YX; Jin X; Tang X; Zhang J; Li H; Li YK; Tang ZZ
Sci Rep; 2023 Nov; 13(1):19474. PubMed ID: 37945610
[TBL] [Abstract] [Full Text] [Related]
15. Golgi Phosphoprotein 3 Promotes cervical cancer Progression via Wnt/β-catenin Mediated Epithelial-Mesenchymal Transition.
Yang H; Ma X; Song B; Wang D; Chai Z
Ann Clin Lab Sci; 2023 Sep; 53(5):738-748. PubMed ID: 37945014
[TBL] [Abstract] [Full Text] [Related]
16. Machine Learning-Based Models for Assessing Postoperative Risk Factors in Patients with cervical cancer.
Yu Z; Zhihui Q; Linrui L; Long L; Qibing W
Acad Radiol; 2024 Apr; 31(4):1410-1418. PubMed ID: 37891091
[TBL] [Abstract] [Full Text] [Related]
17. Validation of an on-chip p16
Hashimoto K; Kumagai T; Nomura K; Miyagawa Y; Tago S; Takasaki K; Takahashi Y; Nishida H; Ichinose T; Hirano M; Hiraike H; Wada-Hiraike O; Sasajima Y; Kim SH; Nagasaka K
Sci Rep; 2023 Oct; 13(1):17052. PubMed ID: 37816765
[TBL] [Abstract] [Full Text] [Related]
18. Down-regulation of human papillomavirus E6 oncogene and antiproliferative effect of Schisandra chinensis and Pueraria lobata natural extracts on Hela cell line.
Cardona-Mendoza A; Fonseca-Benitez A; Buitrago DM; Coy-Barrera E; Perdomo SJ
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117225. PubMed ID: 37797877
[TBL] [Abstract] [Full Text] [Related]
19. HPV Testing and its Role in cervical cancer Screening.
Clarke MA
Clin Obstet Gynecol; 2023 Sep; 66(3):448-469. PubMed ID: 37650662
[TBL] [Abstract] [Full Text] [Related]
20. The relationship of immunohistochemical SOX-2 staining with histopathological diagnosis in patients with abnormal colposcopic findings.
Atıgan A; Kılıç D; Karakaya YA; Gök S; Güler ÖT
Histochem Cell Biol; 2023 Dec; 160(6):555-561. PubMed ID: 37558931
[TBL] [Abstract] [Full Text] [Related]
[Next]
